Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
ixmyelocel-t (1 trial)
fibrinolysin, human (1 trial)
Arterial Occlusive Diseases (Phase 1)
Ischemia (Phase 2)
Peripheral Arterial Disease (Phase 2)
Peripheral Vascular Diseases (Phase 2)
Trials (2 total)
Trial APIs (2 total)